SCHEMBL1033717

SCHEMBL1033717

COc1ccc(Cl)cc1-c1ccnc(NC2CCC(C)(C)CC2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.48
IKBKB O14920 4/20 0.46
MAPK8 P45983 4/20 0.45
MAPK9 P45984 3/20 0.45
MAPK10 P53779 3/20 0.45
EIF2AK2 P19525 1/20 0.45
AGPAT2 O15120 2/20 0.43
CDK4 P11802 3/20 0.43
GSK3B P49841 1/20 0.43
KCNH2 Q12809 1/20 0.43
HDAC8 Q9BY41 3/20 0.42
CDK2 P24941 3/20 0.41
CDK1 P06493 2/20 0.41
CCNB1 P14635 2/20 0.41
CCNA2 P20248 2/20 0.41
CCND1 P24385 2/20 0.41
CCNA1 P78396 2/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
JAK2 O60674 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1032622 0.91 MAPK10 (0.49) SMN1; SMN2IKBKBMAPK8MAPK9MAPK10
SCHEMBL1034516 0.89 SMN1; SMN2 (0.60) SMN1; SMN2IKBKBMAPK8MAPK9MAPK10
SCHEMBL1032136 0.88 SMN1; SMN2 (0.62) SMN1; SMN2IKBKBMAPK8MAPK9MAPK10
SCHEMBL3620677 0.88 SMN1; SMN2 (0.62) SMN1; SMN2IKBKBMAPK8MAPK9MAPK10
SCHEMBL12955857 0.87 SMN1; SMN2 (0.53) SMN1; SMN2IKBKBMAPK8MAPK9MAPK10
SCHEMBL3654146 0.87 SMN1; SMN2 (0.53) SMN1; SMN2IKBKBMAPK8MAPK9MAPK10
SCHEMBL1032761 0.81 IKBKB (0.49) SMN1; SMN2IKBKBMAPK8MAPK9MAPK10
SCHEMBL1031273 0.80 HDAC8 (0.56) HDAC8
SCHEMBL1074198 0.79 IKBKB (0.47) SMN1; SMN2IKBKBMAPK8MAPK9CDK4
SCHEMBL1032314 0.77 CDK2 (0.46) SMN1; SMN2IKBKBMAPK8MAPK9MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO disclosed